300 million life-years have been lost to cardiovascular diseases.1 Abbott's Beyond Intervention Research addresses new demands of today's diverse patient care landscape and new approaches on the horizon. It's time we reimagine patient care.
In its third year, our new research focuses on the later stages of the patient experience following hospital discharge or after an intervention (whether lifestyle modification recommendations, prescribed medications or a surgical or endovascular procedure). A total of 2,056 stakeholders across 16 countries answered a structured questionnaire between March and May 2022 that informed this research.
For over 135 years, Abbott has been committed to building life-changing technologies that keep people healthy, providing nutritional support and novel medicines, and developing diagnostic tests and breakthrough tools to help people manage their health. Today, Abbott reaches 2 billion people annually through best-in-class products and technologies, with an aim of increasing this to 3 billion (1 in 3 people on the planet) by 2030. As part of this bold mission, Abbott’s Vascular business is putting science and innovation to work to create more possibilities for more people.
Throughout the course of this 3-year research program, comprising nearly 5,500 individual surveys, clear insights into the care experiences of vascular patients have emerged, alongside potential technological solutions that could improve end-to-end patient experiences, including:
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?